期刊文献+

ATP-竞争性mTOR抑制剂Wye-125132的合成

Synthesis of ATP-competitive inhibitor Wye-125132
原文传递
导出
摘要 目的合成mTOR通路抑制剂Wye-125132,确立一条适用于工业化生产的合成路线。方法以巴比妥酸为原料经Vilsmeier-Haack甲酰化、氯代反应合成中间体2,4,6-三氯-嘧啶-5-甲醛2,以1,4-环己二酮单乙二醇缩酮为原料,经3步反应得到中间体5,化合物2与5缩合后,再经取代反应合成关键中间体7。以对溴苯胺为原料经3步反应得侧链9,将9与7经Suzuki偶联反应得目标产物1。中间体及目标化合物的结构经MS和1H-NMR确认。结果与讨论新的合成路线反应总收率为13.2%,产物纯度为99.77%。新的合成路线具有原料易得、操作简便、反应条件温和、无需柱层析等优点,适合工业化生产。 Objective To synthesize Wye-125132,an inhibitor of mTOR,and to establish a synthetic route for industrial production. Methods Barbituric acid was used as the raw material to synthesize the intermediate 2,4,6-trichrolopyrimidine-5-carbaldehyde 2 via Vilsmeier-Haack and chlorination reaction,while intermediate 5 was prepared via 3-step reaction from 1,4-dioxaspiro-[4,5]decan-8-one. The condensation of 2 and 5 was followed by substitution reaction to obtain the key intermediate 7. The side chain 9 was prepared by 3-step reaction from bromine aniline. Then the title product 1 was obtained with the reaction of Suzuki cross-coupling of 7 and 9. The structures of intermediate and target compounds were confirmed by MS and1H-NMR. Results and Conclusion Compared with the method reported in the literature,this new synthesis method possesses some advantages,such as ready availablity of raw materials,simple operation,mild reaction conditions and easy disposal of products. The total yield is 13. 2%,and the purity of the target compound is 99. 77%.
出处 《军事医学》 CAS CSCD 北大核心 2016年第8期643-645,685,共4页 Military Medical Sciences
基金 中国博士后科学基金面上资助项目(2015M572756)
关键词 MTOR抑制剂 Wye-125132 ATP-竞争性抑制剂 mTOR inhibitor Wye-125132 ATP-competitive inhibitor
  • 相关文献

参考文献8

  • 1Yu K, Shi C, Toral BL, et al. Beyond rapalog therapy: preclini- cal pharmacology and antitumor activity of WYE-125132, an ATP- competitive and specific inhibitor of mTORC1 and mTORC2[ Jl. Cancer Res, 2010,70(2) :621 -631. 被引量:1
  • 2Curran K J, Verheijen JC, Kaplan J, et al. Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin ( mTOR ) : optimization of the 1- substituent[J]. Bioorg Med Chem Lett, 2010,20(4):1440 -1444. 被引量:1
  • 3Yu K, Toral BL, Shi C, et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin [ J ]. Cancer Res, 2009,69 ( 15 ) : 6232 - 6240. 被引量:1
  • 4Zask A, Koplan A, Verheijen JC, et al. Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors:US,US8129371 [ P]. 2012 -05 -06. 被引量:1
  • 5Artigas G, MarchOn V. Synthesis of Janus compounds for the recognition of G-U mismatched nucleobase pairs[J]. J Org Chem, 2013,78(21 ) :10666 - 10677. 被引量:1
  • 6施成进.对溴苯异氰酸酯的合成研究[J].丽水学院学报,2010,32(5):30-32. 被引量:2
  • 7Wang J, Liang YL, Qu J. Boiling water-catalyzed neutral and selective N-Boc deprotection [ J ]. Chem Commun, 2009, ( 34 ) : 5144 - 5146. 被引量:1
  • 8Yoshihiko N, Nobuaki S, Yuki I, et al. Pyridinylpyrazoloquino- line eornponnd : Japan, WO2014163146 [ P ]. 2014 - 10 - 09. 被引量:1

二级参考文献6

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部